ResearcherInsermActive in the last 2 years
Elie Rassy
Matched on ORCID iD 0000-0002-7906-0991; OpenAlex author ID A5029091749, A5135073789. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 5
- Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK Biobank. Co-author DOI 10.1016/j.ejca.2026.116767↗
- Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health … Co-author DOI 10.1038/s41416-026-03597-6↗
- Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of p… Co-author DOI 10.1038/s41416-025-03172-5↗
- Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospe… Co-author DOI 10.1016/j.clinre.2016.11.012↗
- Dilemma of first line regimens in metastatic pancreatic adenocarcinoma. Co-author DOI 10.3748/wjg.v22.i46.10124↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alice Boilève · 3 shared papers, 2025–2026 · strength 0.90
- Paper Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK … DOI 10.1016/j.ejca.2026.116767↗
- Paper Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medi… DOI 10.1038/s41416-026-03597-6↗
- Paper Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in n… DOI 10.1038/s41416-025-03172-5↗
- Maryam Karimi · 3 shared papers, 2025–2026 · strength 0.90
- Paper Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK … DOI 10.1016/j.ejca.2026.116767↗
- Paper Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medi… DOI 10.1038/s41416-026-03597-6↗
- Paper Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in n… DOI 10.1038/s41416-025-03172-5↗
- Tarek Assi · 2 shared papers, 2016–2017 · strength 0.16
- Marwan G. Ghosn · 2 shared papers, 2016–2017 · strength 0.16
- Joseph Gergi Kattan · 2 shared papers, 2016–2017 · strength 0.16
- Hampig Raphaël Kourié · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.